Variant report
Variant | esv3430941 |
---|---|
Chromosome Location | chr3:163297758-163302156 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163296408..163298794-chr3:163316972..163318704,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146928142 | chr3:163299805-163299806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs137952456 | chr3:163299835-163299836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375264292 | chr3:163299850-163299851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372397150 | chr3:163299853-163299854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569344075 | chr3:163299896-163299897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537998810 | chr3:163299919-163299920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549450038 | chr3:163299922-163299923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1841354 | chr3:163299930-163299931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs534770631 | chr3:163299935-163299936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577651008 | chr3:163300001-163300002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs58398653 | chr3:163300004-163300005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1841353 | chr3:163300028-163300029 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs553015436 | chr3:163300045-163300046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573050798 | chr3:163300057-163300058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571533074 | chr3:163300063-163300064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183624399 | chr3:163300089-163300090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561964382 | chr3:163300107-163300108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138031194 | chr3:163300137-163300138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575488257 | chr3:163300173-163300174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371336276 | chr3:163300200-163300201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544355320 | chr3:163300204-163300205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575295479 | chr3:163300218-163300219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534636344 | chr3:163300255-163300256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564133655 | chr3:163300278-163300279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368860750 | chr3:163300297-163300298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532976728 | chr3:163300328-163300329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570765188 | chr3:163300373-163300374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187977627 | chr3:163300444-163300445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374659370 | chr3:163300463-163300464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72619314 | chr3:163300478-163300479 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs75615013 | chr3:163300512-163300513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549411034 | chr3:163300513-163300514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569463334 | chr3:163300519-163300520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372922512 | chr3:163300538-163300539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538033643 | chr3:163300540-163300541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs180849653 | chr3:163300553-163300554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1599269 | chr3:163300582-163300583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs573525344 | chr3:163300594-163300595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554178258 | chr3:163300643-163300644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567548407 | chr3:163300662-163300663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73161810 | chr3:163300672-163300673 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs186520997 | chr3:163300702-163300703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189767335 | chr3:163300746-163300747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181864787 | chr3:163300767-163300768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186846941 | chr3:163300768-163300769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191130423 | chr3:163300772-163300773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539945425 | chr3:163300824-163300825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560142563 | chr3:163300827-163300828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181775493 | chr3:163300863-163300864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537974577 | chr3:163300879-163300880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163299800-163301800 | Enhancers | Liver | Liver |